Assertio Holdings（ASRT）株式概要
製薬会社であるアサーティオ・ホールディングスは、米国で様々な製品を患者に提供している。 詳細
ASRT Community Fair Values
Create NarrativeSee what 29 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Assertio Holdings, Inc. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$23.46 |
| 52週高値 | US$23.46 |
| 52週安値 | US$8.61 |
| ベータ | 0.45 |
| 1ヶ月の変化 | 30.04% |
| 3ヶ月変化 | 97.97% |
| 1年変化 | 130.51% |
| 3年間の変化 | -75.79% |
| 5年間の変化 | -12.63% |
| IPOからの変化 | -90.23% |
最新ニュース
ナラティブの更新 • May 22
ASRT: Zydus Cash Deal And Garda Termination Will Shape 2026 Outlook
Analysts have raised their price expectations for Assertio Holdings to $23.50 per share from $21.80, citing the terminated Garda amendment and the agreed all-cash acquisition by Zydus Worldwide at $23.50 per share as the key drivers of the updated target and valuation inputs. Analyst Commentary Recent research has highlighted a split in sentiment around Assertio Holdings, even as the all cash acquisition price has become the main reference point for valuation.
ナラティブの更新 • May 03
ASRT: Takeover Agreement And CVR Structure Will Support Future Repricing Potential
Narrative Update on Assertio Holdings The latest analyst price target for Assertio Holdings has been revised to $21.33. Analysts cite the recent downgrades following the takeover agreement as the key factor behind their updated view.ナラティブの更新 • Apr 19
ASRT: Takeover Agreement Will Support Earnings Power And Rerating Potential
Analysts have adjusted Assertio Holdings' price target from about $37.44 to roughly $21.33, reflecting updated views on softer revenue growth, slightly lower profit margins, and a reduced future P/E assumption following recent downgrades related to its takeover agreement. Analyst Commentary Recent research around Assertio Holdings has centered on its takeover agreement and what that means for execution risk, profit quality, and where the shares should trade relative to prior expectations.Recent updates
ナラティブの更新 • May 22
ASRT: Zydus Cash Deal And Garda Termination Will Shape 2026 Outlook
Analysts have raised their price expectations for Assertio Holdings to $23.50 per share from $21.80, citing the terminated Garda amendment and the agreed all-cash acquisition by Zydus Worldwide at $23.50 per share as the key drivers of the updated target and valuation inputs. Analyst Commentary Recent research has highlighted a split in sentiment around Assertio Holdings, even as the all cash acquisition price has become the main reference point for valuation.ナラティブの更新 • May 03
ASRT: Takeover Agreement And CVR Structure Will Support Future Repricing Potential
Narrative Update on Assertio Holdings The latest analyst price target for Assertio Holdings has been revised to $21.33. Analysts cite the recent downgrades following the takeover agreement as the key factor behind their updated view.ナラティブの更新 • Apr 19
ASRT: Takeover Agreement Will Support Earnings Power And Rerating Potential
Analysts have adjusted Assertio Holdings' price target from about $37.44 to roughly $21.33, reflecting updated views on softer revenue growth, slightly lower profit margins, and a reduced future P/E assumption following recent downgrades related to its takeover agreement. Analyst Commentary Recent research around Assertio Holdings has centered on its takeover agreement and what that means for execution risk, profit quality, and where the shares should trade relative to prior expectations.ナラティブの更新 • Apr 04
ASRT: Reverse Split And 2026 Guidance Will Shape Future Upside Potential
Analysts have kept Assertio Holdings' fair value estimate steady at $28.00, while modestly refining their assumptions around revenue growth, profit margins, and future P/E. This has led to a recalibrated price target that they see as better aligned with updated fundamentals.ナラティブの更新 • Mar 21
ASRT: Reverse Split And 2026 Guidance Will Reshape Risk Reward Profile
Analysts have raised their price target on Assertio Holdings from $1.75 to $28.00, citing updated assumptions for revenue growth, profit margins, discount rate, and a lower future P/E multiple in their models. Analyst Commentary Even with a sharply higher price target in some models, not all research views point in the same direction for Assertio Holdings.ナラティブの更新 • Mar 07
ASRT: Reverse Split And Earnings Power Will Support Rerating Potential
Analysts have raised their price target on Assertio Holdings, maintaining the figure at $37.44, while citing updated views on fair value, discount rate, revenue growth, profit margin and future P/E as the reasons for the revised assessment. Analyst Commentary Bullish Takeaways Bullish analysts view the reaffirmed $37.44 price target as consistent with their updated fair value work, suggesting the current share price still leaves room for upside if execution tracks their assumptions.
ナラティブの更新 • Feb 21
ASRT: Cost Discipline And 15% Margins Will Support Future Upside Potential
Analysts have revised their price target for Assertio Holdings to $45.00. The update reflects slightly adjusted assumptions around discount rate, revenue growth, profit margin and future P/E expectations.分析記事 • Feb 07
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Bounce 35% But Its Business Still Trails The Industry
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders would be excited to see that the share price has had a great...ナラティブの更新 • Feb 07
ASRT: Reverse Split And Earnings Visibility Will Reframe Risk Reward Profile
Analysts have modestly adjusted their price target for Assertio Holdings, citing updated views on discount rates, long term revenue trends and sustainable profit margins, along with a slightly higher assumed future P/E multiple. Analyst Commentary Recent Street research on a comparable operator in the transport and infrastructure space, Asur, offers a useful reference point for how analysts are currently weighing valuation against execution risk when traffic and revenue visibility are in focus.ナラティブの更新 • Jan 24
ASRT: Cost Discipline And 15% Margins Will Support Future Upside Potential
Analysts have trimmed their price target on Assertio Holdings to $45.00 from $44.99, reflecting updated assumptions that indicate a smaller revenue decline, higher profit margins near 15%, and a lower future P/E closer to 16x. Analyst Commentary Bullish analysts in the wider market are pointing to companies that maintain or improve profitability targets and trade on mid-teens P/E multiples as potential opportunities for re-rating when execution holds up.ナラティブの更新 • Jan 10
ASRT: Reverse Split And New Leadership Will Reframe Risk Reward Profile
Analysts lifted their fair value estimate for Assertio Holdings from $2.69 to $37.44, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E as the key drivers of the new price target range. Analyst Commentary Recent Street research on airport operators with similar business profiles offers some context for how analysts might be thinking about Assertio Holdings, particularly around traffic trends, valuation ranges, and the balance between upside potential and execution risk.ナラティブの更新 • Dec 26
ASRT Will Rely On Cost Discipline To Support Future Upside Potential
Analysts have raised their price target on Assertio Holdings significantly, from approximately $3.00 to about $45.00. This reflects a higher assumed fair value multiple despite more conservative expectations for revenue growth and profit margins.分析記事 • Dec 24
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Lagging The Industry But So Is The Business
Assertio Holdings, Inc.'s ( NASDAQ:ASRT ) price-to-sales (or "P/S") ratio of 0.5x might make it look like a strong buy...分析記事 • Sep 18
Is Assertio Holdings (NASDAQ:ASRT) Using Debt In A Risky Way?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...分析記事 • May 15
Assertio Holdings, Inc. (NASDAQ:ASRT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
Assertio Holdings, Inc. ( NASDAQ:ASRT ) missed earnings with its latest first-quarter results, disappointing...分析記事 • Apr 30
Is Assertio Holdings (NASDAQ:ASRT) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
新しいナラティブ • Apr 28
Rolvedon And Sympazan Will Create New Market Opportunities
Strategic market penetration and increased commercial efforts for Rolvedon and Sympazan aim to boost revenue growth.分析記事 • Mar 14
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues Are Not Doing Enough For Some Investors
Assertio Holdings, Inc.'s ( NASDAQ:ASRT ) price-to-sales (or "P/S") ratio of 0.6x might make it look like a strong buy...分析記事 • Dec 24
Is Assertio Holdings (NASDAQ:ASRT) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...分析記事 • Nov 15
Little Excitement Around Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues As Shares Take 25% Pounding
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders that were waiting for something to happen have been dealt a blow...分析記事 • Sep 25
Is Assertio Holdings (NASDAQ:ASRT) Using Debt Sensibly?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Aug 19
Assertio Holdings, Inc. (NASDAQ:ASRT) Not Doing Enough For Some Investors As Its Shares Slump 30%
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have retraced a considerable 30% in the last month, reversing a fair...分析記事 • Jul 04
There's No Escaping Assertio Holdings, Inc.'s (NASDAQ:ASRT) Muted Revenues Despite A 36% Share Price Rise
Despite an already strong run, Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have been powering on, with a gain of 36...分析記事 • May 07
Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
Despite an already strong run, Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have been powering on, with a gain of 29...分析記事 • Apr 18
Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...分析記事 • Mar 13
Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders are no doubt pleased to see that the share price has bounced 26...株主還元
| ASRT | US Pharmaceuticals | US 市場 | |
|---|---|---|---|
| 7D | 0.2% | 5.4% | 1.2% |
| 1Y | 130.5% | 44.3% | 28.7% |
業界別リターン: ASRT過去 1 年間で44.3 % の収益を上げたUS Pharmaceuticals業界を上回りました。
リターン対市場: ASRT過去 1 年間で28.7 % の収益を上げたUS市場を上回りました。
価格変動
| ASRT volatility | |
|---|---|
| ASRT Average Weekly Movement | 9.2% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
安定した株価: ASRT 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。
時間の経過による変動: ASRTの 週次ボラティリティ ( 9% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 2020 | 53 | Mark L. Reisenauer | www.assertiotx.com |
製薬会社であるAssertio Holdings, Inc.は、米国で様々な製品を患者に提供している。同社の医薬品には、慢性疾患の急性再燃を含む中等度から重度の関節リウマチ、強直性脊椎炎および変形性関節症、急性有痛性肩関節症および痛風関節症の治療薬である内服液および座薬のINDOCINが含まれる。また、2歳以上のレノックス・ガストー症候群に伴うてんかん発作の併用療法を適応とするベンゾジアゼピン系抗てんかん薬Sympazan、片頭痛の痛み、吐き気、羞明、羞声の治療を適応とする非ステロイド性抗炎症薬（NSAID）CAMBIAも提供している；オピオイドレベルの鎮痛を必要とする中等度から中等度の激痛の短期管理用非ステロイド性抗炎症薬SPRIX、発熱性好中球減少症による感染症の発生率減少を適応とする長時間作用型顆粒球コロニー刺激因子ROLVEDON。同社は以前Assertio Therapeutics, Inc.として知られていたが、2020年5月にAssertio Holdings, Inc.に社名を変更した。アサーティオ・ホールディングスは2020年に法人化され、イリノイ州レイクフォレストに本社を置いている。
Assertio Holdings, Inc. 基礎のまとめ
| ASRT 基礎統計学 | |
|---|---|
| 時価総額 | US$151.47m |
| 収益（TTM） | -US$35.69m |
| 売上高(TTM) | US$102.16m |
1.5x
P/Sレシオ-4.2x
PER（株価収益率ASRT は割高か？
公正価値と評価分析を参照収益と収入
| ASRT 損益計算書（TTM） | |
|---|---|
| 収益 | US$102.16m |
| 売上原価 | US$30.31m |
| 売上総利益 | US$71.85m |
| その他の費用 | US$107.54m |
| 収益 | -US$35.69m |
直近の収益報告
Mar 31, 2026
次回決算日
該当なし
| 一株当たり利益（EPS） | -5.52 |
| グロス・マージン | 70.33% |
| 純利益率 | -34.94% |
| 有利子負債／自己資本比率 | 51.9% |
ASRT の長期的なパフォーマンスは？
過去の実績と比較を見る企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/26 23:39 |
| 終値 | 2026/05/26 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Assertio Holdings, Inc. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。18
| アナリスト | 機関 |
|---|---|
| Scott Henry | Alliance Global Partners |
| null null | Argus Research Company |
| Kenneth Trbovich | Brean Capital Historical (Janney Montgomery) |